T(11;18)(q21;q21) results in a chimeric transcript between API2 at 11q21 and MALT1 at 18q21 and is a characteristic chromosomal aberration of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). API2-MALT1 chimeric transcripts are present in approximately one-third of all cases of MALT lymphoma. MALT lymphoma is also known to have variations in histological features and tumor cell proportions. Real-time polymerase chain reaction (PCR) was used to examine number of API2-MALT1 copies in clinical samples for further investigation of the pathophysiology of MALT lymphoma. A total of 13 samples of MALT lymphoma contained API2-MALT1 transcripts from 1.7 Â 10 À2 to 1.0 copies/b-actin copy. These findings were compared to the proportions of tumor cells in genomic VDJ PCR products determined by Southern blotting. Tumor cell ratios varied widely among the patients' samples, and no significant correlation was found between transcript copy number and tumor cell ratio. These results suggest that copy numbers of API2-MALT1 do not reflect tumor cell proportions, and that the number of copies of API2-MALT1 in a tumor cell is different for each clinical sample.
Introduction
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) constitutes 7-8% of all B-cell lymphomas. 1 The most common cytogenetic abnormality of MALT lymphoma is t(11;18)(q21;q21), a translocation in which API2 on chromosome 11 band q21 is juxtaposed to MALT1 on chromosome 18 band q21. [2] [3] [4] [5] [6] [7] [8] Our study found that this translocation is observed in 12% of gastric MALT lymphomas, 63% of pulmonary cases and 100% of colon cases. 9 In contrast, the API2-MALT1 chimeric transcript is not found in either the nodal marginal zone or primary gastric large B-cell lymphomas. [10] [11] [12] This characteristic genetic abnormality is thought to be essential for the oncogenesis or progression of MALT lymphoma.
Histological variations have been observed in instances of MALT lymphoma. [13] [14] [15] Some cases show lymphoma cells colonizing the germinal center of the reactive follicles that are a result of chronic inflammation, [16] [17] [18] while others show a diffuse monotonous pattern. These variations in histology and tumor cell proportions in MALT lymphomas may be clinically and physiologically significant.
To identify the biologic features of MALT lymphoma in more detail, we examined the numbers of API2-MALT1 copies in samples from 13 patients. For the assessment of tumor cell ratios, genomic polymerase chain reaction (PCR) amplification of rearranged immunoglobulin heavy chain (IgH) was performed, and Southern hybridization was conducted. These studies were conducted to investigate the possible existence of a relationship between copy numbers of API2-MALT1 and tumor cell ratios in MALT lymphoma samples.
Materials and methods

Patients and specimens
A total of 13 patient samples with the most frequent type of API2-MALT1 chimeric transcripts (API2 exon 7-MALT1 exon 5) 8 were used for assessment (Table 1) . Six cases originated in the lung, five cases in the stomach, one in the colon, and one in the pleural cavity. The materials were used with the informed consent of the patients and the approval of the Institutional Review Board of the Aichi Cancer Center.
RNA extraction
Total RNAs were prepared with the guanidium-isothiocyanate method. 19 Total RNA was converted to cDNA by means of SUPERSCRIPT TM II reverse transcriptase (GIBCO-BRL, Bethesda, MD, USA), according to the manufacturer's protocol.
Real-time PCR of API2-MALT1
The PCR was conducted in a total volume of 25 ml containing 125 ng of template cDNA, 1.25 U of TaKaRa Ex Taq and Taq antibody (TaKaRa, Ohtsu, Japan), 3.5 mmol/l of MgCl 2 , 0.2 mmol/l of each dNTP, 0.32 mmol/l of each primer, and 1/ 25 000 of SYBR Green I (BioWhittaker Molecular Applications, FL, USA). The primers were 5 0 -CAAGTTCAAGCCAGTTACCCT-CATCTACTTG-3 0 (API2 exon 5, sense) and 5 0 -AACTTGGATT-CAGAGACGCCATCAACACTTC-3 0 (MALT1 exon 5, antisense). The PCR was performed with precycling at 951C for 10 min, followed by 40 cycles of denaturation at 951C for 30 s, annealing at 631C for 30 s, and extension at 721C for 45 s in a Smart Cycler System (TaKaRa). For reference, the b-actin gene was amplified with a previously reported method with slight modification. 20 For the generation of standard curves, the plasmid containing the RT-PCR amplified API2-MALT1 chimeric cDNA sequence of the most frequent type was used. 8 The plasmid was diluted from 10 2 to 10 7 copies in 5 ml dH 2 O containing 125 ng human placental cDNA, and was used as the template.
The standard curve was generated with the serially diluted plasmid samples by using the threshold cycles (C t ) at which the fluorescence signals rose above the baseline signal. The number of copies of API2-MALT1 in each of the 13 clinical samples was calculated by plotting the C t on the standard curve, and values were normalized relative to the expression of b-actin.
Genomic PCR amplification of rearranged IgH VDJ genes and Southern blot analysis
For evaluation of tumor cell ratios of MALT lymphoma samples, genomic DNA was amplified with FR2A (5 0 -TGGA/ G TCCGC/ A CAGG/ C CT/ C T/ C CNGG-3 0 ) and LJH (5 0 -TGAGGAGACGGT-GACC-3 0 ) primers. 21 Simultaneous DNA preparation was possible for nine samples that were subjected to the real-time PCR. Genomic PCR was conducted at two different concentrations of each patient's DNA. One was containing 200 ng of a patient's DNA alone and the other 66.7 ng of a patient's DNA and 133.3 ng of human placental DNA. Two lymphoma cell lines (SU-DHL-6 and NCEB-1) were used as controls. These cell lines were selected because SU-DHL-6 had the highest and NCEB-1 had the lowest PCR amplification efficiency among the six tested B-cell lymphoma cell lines (data not shown). The total amount of cell line DNA was 200 ng with or without human placental DNA and various percentages of the tumor DNA, 100, 50, 25, 5, and 1%, were used for the PCR reactions. Genomic PCR of ferritin light chain (FTL) was also performed to evaluate the quality of DNA isolated from samples. 22 The primers were FTL intron 1 (5 0 -CCTCCCGCCCACGAACCCCTGCATTTC-CAGAATCA-3 0 ) and FTL intron 5 (5 0 -CAGGTGAGCGACC-CACCTGGCCCCATAATCACTCG-3 0 ). After the PCR reactions and gel electrophoresis, Southern blot hybridization was performed as described previously, 23 using the VLJH probe (5 0 -GTGACCAGGGTNCCTTGGCCCCAG-3 0 ). After scanning, signal intensity of VDJ rearrangement band was counted by using ImageQant (Molecular Dynamics, Sunnyvale, CA, USA), and normalized by the intensity of the genomic FTL PCR product of the samples. The ratio of normalized VDJ intensity to that of two serially diluted controls (SU-DHL-6 and NCEB-1) was calculated for the evaluation of tumor cell ratios. and Raji (B-cell lymphoma cell line) cells were grown in RPMI 1640 with 10% FCS. Total RNA was extracted from each sample as described above and 5 mg of total RNA was used for Northern blot analysis as described previously. 23 For detection of API2 mRNA, a 1.8k-bp API2 cDNA fragment containing the entire open-reading frame amplified by PCR was used as a probe.
Cell culture and Northern blot analysis
Results and discussion
We investigated API2-MALT1 copy numbers by means of the real-time PCR method to further clarify the pathophysiology of MALT lymphoma. The standard curve was generated as described in Materials and methods (Figure 1) . Calculations of the number of API2-MALT1 mRNA copies in the clinical samples were made with the relative kinetic method using the standard curve, and were normalized relative to the expression of b-actin. API2-MALT1/b-actin ratios of 13 MALT lymphoma samples ranged from 1.7 Â 10 À2 to 1.0 ( Figure 2 ). It was found that API2-MALT1 chimeric transcripts varied among samples by log orders of magnitude.
In order to explore the molecular bases for the variation in API2-MALT1 copy numbers, the tumor cell ratio of each patient was determined with the aid of Southern hybridization for genomic VDJ PCR products. Although one of the nine cases showed reversal amplification ( Figure 3, case 10 ), successful amplification of VDJ rearrangement was observed in seven samples ( Figure 3, cases 1, 3, 5, 7, 8, 12 , and 13). Tumor cell ratios obtained by the relative intensity of the IgH rearrangement band varied from 0.2 to 30.8% (SU-DHL-6 standard) or from 3.0 to 100% (NCEB-1 standard, Figure 4) . The results demonstrated the heterogeneous distribution of tumor cell proportions, and agreed with those of previous histopathological studies. [13] [14] [15] One case showed no PCR product (Figure 3, case 11) , indicating that the primer used in our study did not amplify the VDJ region of the lymphoma cells.
The numbers of API2-MALT1 copies and the proportion of tumor cells are plotted in Figure 4 . Although the number of samples was too small to reach any definitive conclusion, no Copy numbers of b-actin, Â 10 2 copy /125 ng cDNA.
API2-MALT1 copy number in MALT lymphoma M Suguro-Katayama et al correlation was found between transcript copy number and tumor cell ratio. Our results clearly demonstrate that the number of API2-MALT1 copies does not reflect the proportion of tumor cells, and that API2-MALT1 copy numbers in one tumor cell vary significantly in different clinical samples. This is quite different from findings for other types of chimeric transcripts from which tumor cell ratios can be predicted, such as BCR-ABL 24 and AML1-ETO. 25 The variations in chimeric transcripts may be the result of genetic alterations as reported by Starostik et al 26 and SanchezIzquierdo D et al. 27 Alternatively, they may be caused by transcriptional regulation. In an attempt to explore the mechanism responsible for these variations in copy numbers, the expression kinetics of API2 were studied. Since no MALT lymphoma cells were available for the study, we used normal human PBMNCs. When these cells were stimulated with PHA-P, API2 expression rapidly increased by more than two log orders of magnitude within 1 h and remained high for 6 h ( Figure 5 ). Even after 48 h, its expression level was higher than at time 0. We previously reported that MALT1 was also upregulated. 4 It is therefore possible that the chimeric API2-MALT1 gene in MALT lymphoma may be transcriptionally upregulated by various kinds of stimuli. In many cases of MALT lymphoma, there is a history of chronic inflammation such as Helicobacter pyloriassociated gastritis, Sjö gren syndrome, or Hashimoto disease. These inflammations may be the stimuli that upregulate API2-MALT1 transcriptional activity. It is of further interest that lung MALT lymphomas tend to have more API2-MALT1 mRNA copies than the other types of MALT lymphomas (Table 1) . This may reflect differences in the microenvironment among MALT lymphomas arising from various sites. Relative number of copies of API2-MALT1 to b-actin transcripts in MALT patients. API2-MALT1/b-actin ratios of 13 MALT lymphoma samples range from 1.7 Â 10 À2 to 1.0.
Figure 3
Tumor cell ratios determined by Southern blot analysis for genomic VDJ PCR products. For evaluation of tumor cell ratios of MALT lymphoma samples, genomic DNA was amplified with FR2A and LJH primers. After gel electrophoresis and Southern transfer, the membranes were hybridized with the VLJH probe. DNA was available for nine of the 13 MALT lymphoma patients whose samples and specimens were examined with real-time RT-PCR (cases 1-13, as shown in Table 1 ). DNA 200 ng (left lane) and 67 ng (right lane) of each patient were amplified to confirm that the saturation/plateau phase was not reached during the 25 cycles of PCR reactions. The two serially diluted B-cell lymphoma cell lines SU-DHL-6 and NCEB-1 were also amplified as controls. This experiment was repeated twice with similar results.
Figure 4
API2-MALT1/b-actin ratio and tumor cell ratio in patient samples. After Southern hybridization (Figure 3 ), signal intensity of the VDJ rearrangement band was obtained by scanning, and normalized by using the signal intensity of genomic PCR products of the FTL (data not shown). Serially diluted SU-DHL-6 and NCEB-1 were subjected to linear regression analysis, and tumor cell ratios of MALT lymphoma patients were determined by plotting the normalized signal intensity on the regression lines. Triangles represent tumor cell ratios that were estimated by NCEB-1 standard and diamonds represent those estimated by SU-DHL-6 standard. The horizontal line indicates the API2-MALT1/b-actin ratio. Case numbers are shown below the diamonds.
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